• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of pamidronate in breast cancer with bone metastases: a randomized double-blind placebo controlled multicenter study.

作者信息

Hultborn R, Gundersen S, Rydén S, Holmberg E, Carstensen J, Wallgren U B, Kilany S

机构信息

Department of Oncology, Sahlgrenska Hospital, Göteborg, Sweden.

出版信息

Acta Oncol. 1996;35 Suppl 5:73-4. doi: 10.3109/02841869609083974.

DOI:10.3109/02841869609083974
PMID:9142971
Abstract
摘要

相似文献

1
Efficacy of pamidronate in breast cancer with bone metastases: a randomized double-blind placebo controlled multicenter study.
Acta Oncol. 1996;35 Suppl 5:73-4. doi: 10.3109/02841869609083974.
2
Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials.帕米膦酸盐可预防骨骼并发症，对患有乳腺癌和溶骨性骨转移的女性是有效的姑息治疗：两项随机、安慰剂对照试验的长期随访
Cancer. 2000 Mar 1;88(5):1082-90. doi: 10.1002/(sici)1097-0142(20000301)88:5<1082::aid-cncr20>3.0.co;2-z.
3
Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study.帕米膦酸二钠治疗乳腺癌骨转移的疗效：一项随机、双盲、安慰剂对照的多中心研究。
Anticancer Res. 1999 Jul-Aug;19(4C):3383-92.
4
How can we improve the treatment of bone metastases further?我们如何进一步改善骨转移的治疗？
Curr Opin Oncol. 1998 Aug;10 Suppl 1:S7-13.
5
Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects?
Ann Oncol. 1994;5 Suppl 7:S45-7.
6
A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer.一项随机、双盲、II期探索性试验，评估在患有高危乳腺癌骨转移的患者中继续使用帕米膦酸盐或改用唑来膦酸的姑息治疗益处。
Breast Cancer Res Treat. 2016 Jan;155(1):77-84. doi: 10.1007/s10549-015-3646-2. Epub 2015 Dec 7.
7
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2002(1):CD003474. doi: 10.1002/14651858.CD003474.
8
Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study.静脉注射帕米膦酸二钠治疗乳腺癌患者骨转移：一项剂量探索性研究。
Cancer. 1994 Dec 1;74(11):2949-55. doi: 10.1002/1097-0142(19941201)74:11<2949::aid-cncr2820741110>3.0.co;2-q.
9
Bisphosphonate treatment of lytic bone metastases.双膦酸盐治疗溶骨性骨转移瘤
Drugs Aging. 1999 Apr;14(4):241-6. doi: 10.2165/00002512-199914040-00001.
10
Use of bisphosphonates in cancer patients.
Cancer Treat Rev. 1996 Jul;22(4):265-87. doi: 10.1016/s0305-7372(96)90020-1.

引用本文的文献

1
Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project.癌症患者的急性肾损伤和双膦酸盐使用：来自不良药物事件和报告研究（RADAR）项目的报告。
J Oncol Pract. 2013 Mar;9(2):101-6. doi: 10.1200/JOP.2011.000486.
2
Clinical role of bisphosphonate therapy.双膦酸盐治疗的临床作用。
Int J Womens Health. 2012;4:455-69. doi: 10.2147/IJWH.S24783. Epub 2012 Sep 3.
3
Bisphosphonates for the relief of pain secondary to bone metastases.双膦酸盐用于缓解骨转移继发的疼痛。
Cochrane Database Syst Rev. 2002;2002(2):CD002068. doi: 10.1002/14651858.CD002068.
4
Strategies for management of prostate cancer-related bone pain.前列腺癌相关骨痛的管理策略。
Drugs Aging. 2001;18(12):899-911. doi: 10.2165/00002512-200118120-00002.
5
The present and future role of bisphosphonates in the management of patients with breast cancer.双膦酸盐在乳腺癌患者管理中的当前及未来作用。
Breast Cancer Res. 2002;4(1):24-9. doi: 10.1186/bcr413. Epub 2001 Nov 26.
6
Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.帕米膦酸盐。关于其在溶骨性骨转移、肿瘤引起的高钙血症及骨佩吉特病治疗中应用的综述。
Drugs Aging. 1998 Feb;12(2):149-68. doi: 10.2165/00002512-199812020-00007.